Abstract
Ten N-(3-phenylpropyl)-N′-benzylpiperazines having different substituents on the benzyl moiety were synthesized and evaluated for σ1 and σ2 receptor binding. The σ1 affinities were 0.37-2.80 nM, σ2 affinities were 1.03-34.3 nM, and selectivities, as σ2/σ1 affinity ratios, ranged from 1.4 to 52. Three compounds tested in a phenytoin shift binding assay profiled as probable σ1 antagonists. Quantitative structure-activity relationships depended on πx, MR or Es and Hammett σ values. The hydrophobicity term is negative for σ1 binding but positive for σ2 binding, indicating a major difference between the pharmacophores.
Original language | English (US) |
---|---|
Pages (from-to) | 755-761 |
Number of pages | 7 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 16 |
Issue number | 2 |
DOIs | |
State | Published - Jan 15 2008 |
Externally published | Yes |
Keywords
- (+)-(5α,7α,8β)-N-methyl-N-[7-(pyrrolidin-1-yl)-1-oxaspiro[4,5]dec-8-yl]benzeneacetamide
- (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine
- (+)PPP
- 1-(2-(3,4-dimethoxy-phenyl)ethyl)-4-(3-phenylpropyl)piperazine
- DAMGO
- Phenylpiperazines
- QSAR
- Quantitative structure-activity relationship
- SA4503
- Sigma receptor
- Structure-activity relationships
- U69,593
- [d-Ala,N-MePhe,Gly-ol]enkephalin
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry